Brian M. Stolz

2015

In 2015, Brian M. Stolz earned a total compensation of $9.2M as Senior Vice President and General Manager at Valeant Pharmaceuticals International, a 694% increase compared to previous year.

Compensation breakdown

Bonus$50,000
Non-Equity Incentive Plan$594,217
Salary$538,514
Stock Awards$8,022,062
Other$15,927
Total$9,220,720

Stolz received $8M in stock awards, accounting for 87% of the total pay in 2015.

Stolz also received $50K in bonus, $594.2K in non-equity incentive plan, $538.5K in salary and $15.9K in other compensation.

Rankings

In 2015, Brian M. Stolz's compensation ranked 602nd out of 13,638 executives tracked by ExecPay. In other words, Stolz earned more than 95.6% of executives.

ClassificationRankingPercentile
All
602
out of 13,638
96th
Division
Manufacturing
211
out of 5,187
96th
Major group
Chemicals And Allied Products
77
out of 1,857
96th
Industry group
Drugs
58
out of 1,531
96th
Industry
Pharmaceutical Preparations
46
out of 1,179
96th
Source: SEC filing on April 29, 2016.

Stolz's colleagues

We found six more compensation records of executives who worked with Brian M. Stolz at Valeant Pharmaceuticals International in 2015.

2015

J Pearson

Valeant Pharmaceuticals International

Chief Executive Officer

2015

Robert Rosiello

Valeant Pharmaceuticals International

Chief Financial Officer

2015

Anne Whitaker

Valeant Pharmaceuticals International

Group Chairman

2015

Debora Jorn

Valeant Pharmaceuticals International

Group Chairman

2015

Ari Kellen

Valeant Pharmaceuticals International

Group Chairman

2015

Howard Schiller

Valeant Pharmaceuticals International

Chief Financial Officer

You may also like